Literature DB >> 22130249

Morning salivary cortisol and cognitive function in mid-life: evidence from a population-based birth cohort.

M C Geoffroy1, C Hertzman, L Li, C Power.   

Abstract

BACKGROUND: The hormone 'cortisol' has been associated with cognitive deficits in older ages, and also with childhood cognition. The extent to which the associations of cortisol with cognitive deficits in later life reflect associations with childhood cognition ability is unclear. This study aimed to assess associations between adult cortisol levels and subsequent cognitive functions, while considering childhood cognition and other lifetime covariates.
METHOD: Data are from the 1958 British Birth Cohort. Two morning salivary cortisol samples were obtained at 45 years: 45 min after waking (t1) and 3 h later (t2). Standardized tests assessing immediate and delayed verbal memory, verbal fluency and speed of processing were administered at 50 years. Information on cortisol, cognitive outcomes and covariates [e.g., birthweight, lifetime socio-economic position (SEP), education, smoking and drinking habits, body mass index (BMI), menopausal status, and depression/anxiety] was obtained for 4655 participants.
RESULTS: Worse immediate and delayed verbal memory and verbal fluency at 50 years were predicted by elevated t2 cortisol at 45 years. For instance, for 1 standard deviation (s.d.) increase in t2 cortisol, individuals scored -0.05 s.d. lower on verbal memory and fluency tests. Childhood cognition explained about 30% of these associations, but associations with adult cognition remained.
CONCLUSIONS: This study suggests that higher cortisol levels in late morning at 45 years are associated with poorer verbal memory and fluency at 50 years, with a contribution from childhood cognition to these associations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22130249     DOI: 10.1017/S0033291711002704

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  7 in total

Review 1.  Causes and consequences of age-related steroid hormone changes: insights gained from nonhuman primates.

Authors:  K G Sorwell; H F Urbanski
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

2.  Interactive effects of testosterone and cortisol on hippocampal volume and episodic memory in middle-aged men.

Authors:  Matthew S Panizzon; Richard L Hauger; Hong Xian; Kristen Jacobson; Michael J Lyons; Carol E Franz; William S Kremen
Journal:  Psychoneuroendocrinology       Date:  2018-03-09       Impact factor: 4.905

3.  Dysregulation of the hypothalamic pituitary adrenal (HPA) axis and cognitive capability at older ages: individual participant meta-analysis of five cohorts.

Authors:  Michael Gardner; Stafford Lightman; Diana Kuh; Hannie Comijs; Dorly Deeg; John Gallacher; Marie-Claude Geoffroy; Mika Kivimaki; Meena Kumari; Chris Power; Rebecca Hardy; Marcus Richards; Yoav Ben-Shlomo
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

4.  Normalized Cortisol Reactivity Predicts Future Neuropsychological Functioning in Children With Mild/Moderate Asthma.

Authors:  Sarah M Dinces; Lauren N Rowell; Jennifer Benson; Sarah N Hile; Akaysha C Tang; Robert D Annett
Journal:  Front Psychol       Date:  2019-11-19

5.  Sleep and circadian rhythm disturbances in intensive care unit (ICU)-acquired delirium: a case-control study.

Authors:  Ting Sun; Yunliang Sun; Xiao Huang; Jianghua Liu; Jiabin Yang; Kai Zhang; Guiqing Kong; Fang Han; Dong Hao; Xiaozhi Wang
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

6.  Prospective association of morning salivary cortisol with depressive symptoms in mid-life: a life-course study.

Authors:  Marie-Claude Geoffroy; Clyde Hertzman; Leah Li; Chris Power
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

7.  Cortisol and cognitive function in midlife: the role of childhood cognition and educational attainment.

Authors:  Darya Gaysina; Michael P Gardner; Marcus Richards; Yoav Ben-Shlomo
Journal:  Psychoneuroendocrinology       Date:  2014-05-29       Impact factor: 4.905

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.